The Safety and Efficacy of CD-801 in Patients With Advanced Intrahepatic Cholangiocarcinoma
Shanghai Changzheng Hospital
Shanghai Changzheng Hospital
City of Hope Medical Center
Beijing Kejing Biotechnology Co., Ltd.
OHSU Knight Cancer Institute
Roswell Park Cancer Institute
Mainline Biosciences, Inc.
Mayo Clinic
University Hospitals Cleveland Medical Center
BioXcel Therapeutics Inc
OHSU Knight Cancer Institute
University of Texas Southwestern Medical Center
H. Lee Moffitt Cancer Center and Research Institute
Cedars-Sinai Medical Center
Institut Bergonié
Massachusetts General Hospital
Rutgers, The State University of New Jersey
Case Comprehensive Cancer Center
New Hope Medical Center